KEY TOPICS COVERED
Mapping component controls to Annex 1 CCS requirements
How elastomer formulation and coating choices, cleanroom-classified production, automated inspection, particulate testing, and sterilization validation connect directly to Annex 1's contamination control strategy expectations — and where gaps most commonly appear.
Supplier qualification: what to ask and what to request
Which manufacturing, testing, validation, and change-control documents to request during supplier qualification — and how to evaluate whether a supplier's data package is genuinely audit-ready. For elastomer components used in vial closure systems, this includes sterilization method documentation, endotoxin and bioburden data, and extractables and leachables assessments.
Where component-level risk hides in fill-finish operations
Common particulate, endotoxin/pyrogen, and extractables and leachables risk gaps in sterile fill-finish operations that are frequently tied to component decisions made early in development — including container closure integrity failures that only surface under real-world conditions.
